{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T07:10:52Z","timestamp":1793517052348,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370794"],"award-info":[{"award-number":["81370794"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570604"],"award-info":[{"award-number":["81570604"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770666"],"award-info":[{"award-number":["81770666"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Commission of Health and Family Planning, and Office for Traditional Chinese Medicine Development of Shanghai","award":["ZHYY-ZXYJHZX-1-02"],"award-info":[{"award-number":["ZHYY-ZXYJHZX-1-02"]}]},{"name":"Shanghai Municipal Commission of Health and Family Planning","award":["20134095"],"award-info":[{"award-number":["20134095"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.yexcr.2019.07.001","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T14:56:32Z","timestamp":1562079392000},"page":"111488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation"],"prefix":"10.1016","volume":"383","author":[{"given":"Shu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qisheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihua","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yexcr.2019.07.001_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1681\/ASN.2015030234","article-title":"Renal hemodynamics in AKI: in search of new treatment targets","volume":"27","author":"Matejovic","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.yexcr.2019.07.001_bib2","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1681\/ASN.2015070748","article-title":"Tubular epithelial NF-kappaB activity regulates ischemic AKI","volume":"27","author":"Marko","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.yexcr.2019.07.001_bib3","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.ajkd.2015.10.019","article-title":"Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of veterans Health administration data","volume":"67","author":"Heung","year":"2016","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.yexcr.2019.07.001_bib4","doi-asserted-by":"crossref","first-page":"F1078","DOI":"10.1152\/ajprenal.00017.2010","article-title":"Acute kidney injury: a springboard for progression in chronic kidney disease","volume":"298","author":"Venkatachalam","year":"2010","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"5","key":"10.1016\/j.yexcr.2019.07.001_bib5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ki.2012.208","article-title":"Acute kidney injury and chronic kidney disease: an integrated clinical syndrome","volume":"82","author":"Chawla","year":"2012","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.yexcr.2019.07.001_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nm.2144","article-title":"Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury","volume":"16","author":"Yang","year":"2010","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.yexcr.2019.07.001_bib7","doi-asserted-by":"crossref","first-page":"F1187","DOI":"10.1152\/ajprenal.00425.2014","article-title":"Hypoxia as a key player in the AKI-to-CKD transition","volume":"307","author":"Tanaka","year":"2014","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"5","key":"10.1016\/j.yexcr.2019.07.001_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrneph.2015.3","article-title":"Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD","volume":"11","author":"Ferenbach","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.yexcr.2019.07.001_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","article-title":"An integrated view of cisplatin-induced nephrotoxicity and ototoxicity","volume":"237","author":"Karasawa","year":"2015","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.yexcr.2019.07.001_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cisplatin nephrotoxicity: a review of the literature","volume":"31","author":"Manohar","year":"2018","journal-title":"J. Nephrol."},{"issue":"7","key":"10.1016\/j.yexcr.2019.07.001_bib11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2215\/CJN.08070715","article-title":"Long-term renal outcomes after cisplatin treatment","volume":"11","author":"Latcha","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.yexcr.2019.07.001_bib12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/COC.0000000000000301","article-title":"Retrospective analysis of cisplatin nephrotoxicity in patients with head and neck cancer receiving outpatient treatment with concurrent high-dose cisplatin and radiotherapy","volume":"41","author":"Faig","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.yexcr.2019.07.001_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142225","article-title":"Understanding the risk factors and long-term consequences of cisplatin-associated acute kidney injury: an observational cohort study","volume":"10","author":"Bhat","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.yexcr.2019.07.001_bib14","doi-asserted-by":"crossref","first-page":"F560","DOI":"10.1152\/ajprenal.00512.2015","article-title":"Repeated administration of low-dose cisplatin in mice induces fibrosis","volume":"310","author":"Sharp","year":"2016","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"2","key":"10.1016\/j.yexcr.2019.07.001_bib15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ki.2015.327","article-title":"Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition","volume":"89","author":"Katagiri","year":"2016","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.yexcr.2019.07.001_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ndt\/gft332","article-title":"Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis","volume":"29","author":"Lorenz","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7","key":"10.1016\/j.yexcr.2019.07.001_bib17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.yexcr.2019.07.001_bib18","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2010020143","article-title":"The NLRP3 inflammasome promotes renal inflammation and contributes to CKD","volume":"21","author":"Vilaysane","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.yexcr.2019.07.001_bib19","doi-asserted-by":"crossref","first-page":"F1081","DOI":"10.1152\/ajprenal.00534.2015","article-title":"NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mouse with 5\/6 nephrectomy","volume":"310","author":"Gong","year":"2016","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"3","key":"10.1016\/j.yexcr.2019.07.001_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.kint.2016.03.035","article-title":"An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice","volume":"90","author":"Ludwig-Portugall","year":"2016","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.yexcr.2019.07.001_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1681\/ASN.2012040414","article-title":"Adiponectin promotes functional recovery after podocyte ablation","volume":"24","author":"Rutkowski","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.yexcr.2019.07.001_bib22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41419-018-1023-x","article-title":"Caspase-11-mediated tubular epithelial pyroptosis underlies contrast-induced acute kidney injury","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.yexcr.2019.07.001_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.yexcr.2019.07.001_bib24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.yexcr.2019.07.001_bib25","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/art.40155","article-title":"Podocyte activation of NLRP3 inflammasomes contributes to the development of proteinuria in lupus nephritis","volume":"69","author":"Fu","year":"2017","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.yexcr.2019.07.001_bib26","doi-asserted-by":"crossref","first-page":"F835","DOI":"10.1152\/ajprenal.00285.2017","article-title":"Developing better mouse models to study cisplatin-induced kidney injury","volume":"313","author":"Sharp","year":"2017","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"2","key":"10.1016\/j.yexcr.2019.07.001_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ki.2012.20","article-title":"Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis","volume":"82","author":"Grgic","year":"2012","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.yexcr.2019.07.001_bib28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","article-title":"Renal tubule injury: a driving force toward chronic kidney disease","volume":"93","author":"Liu","year":"2018","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.yexcr.2019.07.001_bib29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/jpet.113.205732","article-title":"NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury","volume":"346","author":"Kim","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yexcr.2019.07.001_bib30","doi-asserted-by":"crossref","first-page":"8316560","DOI":"10.1155\/2017\/8316560","article-title":"NLRP3 deficiency attenuates renal fibrosis and ameliorates mitochondrial dysfunction in a mouse unilateral ureteral obstruction model of chronic kidney disease","volume":"2017","author":"Guo","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.yexcr.2019.07.001_bib31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.freeradbiomed.2018.11.006","article-title":"N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin 1 activation and p53 deacetylation","volume":"130","author":"Li","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"13","key":"10.1016\/j.yexcr.2019.07.001_bib32","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/ars.2014.5994","article-title":"Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?","volume":"22","author":"Abais","year":"2015","journal-title":"Antioxidants Redox Signal."},{"issue":"43","key":"10.1016\/j.yexcr.2019.07.001_bib33","doi-asserted-by":"crossref","first-page":"15514","DOI":"10.1073\/pnas.1414859111","article-title":"Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy","volume":"111","author":"Yu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.yexcr.2019.07.001_bib34","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.ajpath.2014.04.005","article-title":"A tissue-specific role for Nlrp3 in tubular epithelial repair after renal ischemia\/reperfusion","volume":"184","author":"Bakker","year":"2014","journal-title":"Am. J. Pathol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482719303295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482719303295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T16:46:57Z","timestamp":1569170817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482719303295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0014482719303295"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2019.07.001","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2019.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111488"}}